Eche Ijeoma Julie, Aronowitz Teri
Dana Farber Cancer Institute, Boston, MA, USA.
University of Massachusetts Boston, Boston, MA, USA.
J Pediatr Oncol Nurs. 2020 May/Jun;37(3):180-194. doi: 10.1177/1043454220907547. Epub 2020 Feb 24.
Despite major advances in acute lymphoblastic leukemia [ALL] treatment, poorer overall survival (OS) persists for Black children with ALL compared with White children with ALL. The purpose of this literature review was to examine the racial disparities on OS in Black versus White children with ALL. The Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medline, PubMed, and Academic Search Complete databases were searched using the Medical Subject Heading (MeSH) terms: survival or mortality or outcome AND black or African-American or AA or minority AND racial disparities or race or racial/ethnic disparities AND cancer in children or pediatric cancer or children with leukemia or children with ALL for articles published in English between January 2009 and July 2019. Exclusion criteria were non-research articles, systematic reviews, conference abstracts, editorials, commentaries, correspondence, and case reports. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, data were extracted, appraised, and synthesized. Sixteen articles met the inclusion criteria. Sample sizes across studies ranged from 184 to 31,866 participants. The factors most associated with disparities in OS included: age at diagnosis (e.g., <1 year and/or >10 years old), differences in clinical prognosticators (e.g., white blood cell count at diagnosis, T-cell vs. precursor B-cell immunophenotype, central nervous system disease status, cytogenetic profile) and lower socioeconomic status. Future prospective studies are needed to elucidate the role of these factors in OS of Black children with ALL.
尽管急性淋巴细胞白血病(ALL)治疗取得了重大进展,但与白人ALL患儿相比,黑人ALL患儿的总体生存率(OS)仍然较低。这篇文献综述的目的是研究黑人与白人ALL患儿在OS方面的种族差异。使用医学主题词(MeSH)检索了护理及相关健康文献累积索引(CINAHL)、Medline、PubMed和学术搜索完整版数据库,检索词为:生存或死亡率或结局、黑人或非裔美国人或AA或少数族裔、种族差异或种族或种族/族裔差异、儿童癌症或儿科癌症或白血病患儿或ALL患儿,检索2009年1月至2019年7月期间发表的英文文章。排除标准为非研究性文章、系统评价、会议摘要、社论、评论、通信和病例报告。按照系统评价和Meta分析的首选报告项目指南,对数据进行提取、评估和综合。16篇文章符合纳入标准。各研究的样本量从184至31,866名参与者不等。与OS差异最相关因素包括:诊断时年龄(如<1岁和/或>10岁)、临床预后因素差异(如诊断时白细胞计数、T细胞与前体B细胞免疫表型、中枢神经系统疾病状态、细胞遗传学特征)以及社会经济地位较低。未来需要进行前瞻性研究,以阐明这些因素在黑人ALL患儿OS中的作用。